Anti-Inflammatory Nutrition: Foods, Peptides and the Research

Disclaimer: This article is written for research and educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional before making any decisions about your health or supplementation.

The Problem of Chronic Inflammation

Inflammation is a fundamental and necessary biological process. Acute inflammation — the redness, swelling, and heat that follows injury or infection — is the immune system's first-line defence. It is time-limited, protective, and essential.

Chronic low-grade inflammation is a different phenomenon entirely. Also termed "inflammageing" when it persists into and through the ageing process, it is characterised by persistently elevated levels of pro-inflammatory cytokines (including CRP, IL-6, IL-1β, and TNF-α) without a clear acute trigger. This ongoing inflammatory state is implicated in the pathophysiology of cardiovascular disease, type 2 diabetes, neurodegenerative conditions, metabolic syndrome, and accelerated biological ageing.

Dietary patterns are among the most significant modifiable drivers of chronic inflammation. The Western dietary pattern — characterised by high intakes of refined carbohydrates, industrial seed oils, processed meats, and ultra-processed foods — consistently elevates inflammatory markers. Conversely, several dietary patterns and specific foods show anti-inflammatory activity across the research literature.

The Mediterranean Dietary Pattern

The Mediterranean diet remains the most evidence-supported dietary pattern for reducing systemic inflammation. Large cohort studies and randomised controlled trials (including the landmark PREDIMED trial) have demonstrated that adherence to a Mediterranean-style diet is associated with:

• Reduced circulating CRP, IL-6, and TNF-α
• Improved endothelial function
• Reduced oxidative stress markers
• Decreased risk of cardiovascular events

The anti-inflammatory components of the Mediterranean diet include olive oil (oleic acid and oleocanthal, a natural COX inhibitor), oily fish (EPA and DHA omega-3 fatty acids), legumes, vegetables (particularly polyphenol-rich varieties), and moderate red wine (resveratrol). Importantly, the synergistic effect of the whole dietary pattern appears greater than the sum of individual food components.

Omega-3 Fatty Acids: The Evidence

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) from marine sources are among the most thoroughly researched anti-inflammatory nutrients. These two fatty acids have distinct but complementary roles — for a detailed breakdown of how to choose between EPA- and DHA-dominant products, see our omega-3 EPA vs DHA comparison. Their mechanisms include:

Competitive inhibition of arachidonic acid metabolism: Omega-3 fatty acids compete with omega-6 arachidonic acid for the same enzymatic pathways (COX and LOX enzymes), reducing the production of pro-inflammatory eicosanoids (prostaglandins, thromboxanes, and leukotrienes) and increasing the production of less inflammatory and pro-resolving lipid mediators.

Production of specialised pro-resolving mediators (SPMs): EPA and DHA are precursors to resolvins, protectins, and maresins — a class of lipid mediators that actively switch off inflammation and promote tissue resolution. This is distinct from simply blocking inflammatory signals; SPMs are anti-inflammatory and pro-resolution.

NF-κB pathway modulation: Omega-3 fatty acids attenuate NF-κB signalling in immune cells, reducing transcription of pro-inflammatory genes.

A meta-analysis published in Nutrition Journal found that EPA/DHA supplementation significantly reduced CRP, IL-6, and TNF-α across a range of clinical populations.

Polyphenols and Plant Bioactives

Polyphenols are a large class of plant secondary metabolites with diverse structures and biological activities. Several have well-characterised anti-inflammatory properties:

Curcumin (from turmeric): Inhibits NF-κB, COX-2, and several pro-inflammatory kinases. Bioavailability is low from standard turmeric but is substantially enhanced by piperine (from black pepper) or lipid-based delivery systems.

Quercetin (from onions, apples, berries): Inhibits histamine release from mast cells, downregulates NF-κB, and demonstrates AMPK-activating properties. Also being researched for senolytic activity. AMPK activation is one of the key pathways through which dietary strategies trigger autophagy induction and cellular cleanup.

EGCG (from green tea): Inhibits NF-κB and AP-1 transcription factors, reduces inflammatory cytokine production, and supports antioxidant enzyme expression.

Resveratrol (from grapes, berries): Activates SIRT1 (an NAD+-dependent deacetylase), inhibits NF-κB, and has demonstrated anti-inflammatory effects in metabolic disease models.

The limitation across many polyphenol studies is bioavailability: the concentrations required to achieve the effects observed in cell studies may not be readily attainable from dietary intake alone, and the gut microbiome substantially determines how dietary polyphenols are metabolised and made available systemically. For a practical, evidence-based implementation of these dietary principles — including specific foods, Australian brands, and a weekly meal framework — see our anti-inflammatory diet protocol.

Bioactive Peptides in Anti-Inflammatory Research

Beyond whole foods and isolated phytochemicals, the field of therapeutic peptides has produced several compounds with notable anti-inflammatory activity. These short peptide sequences act through distinct mechanisms from conventional nutrients, often targeting specific intracellular pathways or receptor systems.

BPC-157 is among the most studied gut-protective peptides. Its anti-inflammatory mechanisms in the gastrointestinal tract — including TNF-α modulation and potential effects on gut barrier integrity — are covered in detail in the gut health and BPC-157 research overview on this site. Note that BPC-157 was rescheduled to Schedule 4 (prescription only) in Australia in March 2025; the TGA peptide regulations guide explains what this means for access and the compounding pathway.

Peptides for metabolic health represent another area of active investigation, with research examining how peptide interventions may reduce inflammatory signalling in metabolically dysregulated tissue.

KPV — the alpha-MSH fragment — demonstrates direct anti-inflammatory activity in gut tissue and is covered in full in the KPV peptide and gut inflammation article.

GHK-Cu modulates inflammatory gene expression through copper-mediated signalling and gene regulation, with applications in skin and wound healing explored in the GHK-Cu skin health research overview.

The Gut Microbiome Connection

Chronic inflammation is increasingly understood to originate, at least in part, from the gut. The composition of the gut microbiome profoundly influences immune system calibration and systemic inflammatory tone. A dysbiotic microbiome — characterised by reduced diversity, overgrowth of pathobionts, and depleted populations of anti-inflammatory species — promotes a state of low-grade endotoxaemia (elevated circulating lipopolysaccharides from gram-negative bacteria) and elevated intestinal and systemic inflammation.

Anti-inflammatory dietary patterns support a more diverse and beneficial microbiome through:

• Fermentable fibres (prebiotics): Feed beneficial bacteria that produce short-chain fatty acids (SCFAs), particularly butyrate, which is a primary fuel for colonocytes and has potent anti-inflammatory and gut barrier-supporting properties. Alongside fibre, L-glutamine — the primary fuel source for enterocytes — is a key nutritional adjunct for maintaining gut barrier integrity under inflammatory conditions
• Fermented foods (probiotics): Associated with increased microbiome diversity and reduced inflammatory markers in recent clinical trials
• Reduced ultra-processed food intake: Emulsifiers and artificial sweeteners found in ultra-processed foods have been shown to disrupt the mucosal layer and alter microbiome composition unfavourably

The relationship between gut barrier integrity and systemic inflammation is explored in depth in the leaky gut research evidence overview, which covers the mechanisms by which dysbiosis, LPS translocation, and tight junction disruption drive chronic inflammatory signalling.

A PubMed Reference

Calder, 2017 — Omega-3 fatty acids and inflammatory processes: From molecules to man provides a rigorous mechanistic and clinical review of omega-3 anti-inflammatory biology.

Summary

The research case for anti-inflammatory nutrition is robust and multifaceted. Dietary patterns centred on whole, minimally processed foods, adequate omega-3 fatty acids, diverse polyphenol-rich plant foods, and gut microbiome-supporting fibres consistently demonstrate reductions in markers of systemic inflammation. The emerging peptide literature adds another layer of mechanistic understanding, pointing to targeted bioactive compounds as potential adjuncts to whole-food anti-inflammatory strategies.